Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiR-33a-5p targets NOMO1 to modulate human cardiomyocyte progenitor cells proliferation and differentiation and apoptosis. | J Recept Signal Transduct Res | 2021 | 33054489 | PubTator, text mining | PubMed |
| Plasma microRNA levels in childhood IgA vasculitis. | Clin Rheumatol | 2021 | 33037530 | PubTator, text mining | PubMed |
| MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells. | Bone | 2021 | 33022453 | PubTator, text mining | PubMed |
| Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer. | J Clin Lab Anal | 2021 | 32965722 | PubTator, text mining | PubMed |
| One locus with two roles: microRNA-independent functions of microRNA-host-gene locus-encoded long noncoding RNAs. | Wiley Interdiscip Rev RNA | 2021 | 32945142 | PubTator, text mining | PubMed |
| NRF2 is a key regulator of endothelial microRNA expression under proatherogenic stimuli. | Cardiovasc Res | 2021 | 32683448 | PubTator, text mining | PubMed |
| MiR-33a inhibits the adipogenic differentiation of ovine adipose-derived stromal vascular fraction cells by targeting SIRT6. | Domest Anim Endocrinol | 2021 | 32653737 | PubTator, text mining | PubMed |
| Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3p. | Exp Dermatol | 2021 | 32592422 | PubTator, text mining | PubMed |
| Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer. | Curr Pharm Biotechnol | 2021 | 32564748 | PubTator, text mining | PubMed |
| The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review. | Curr Neuropharmacol | 2021 | 32359338 | PubTator, text mining | PubMed |
| MicroRNA-33/33* inhibit the activation of MAVS through AMPK in antiviral innate immunity. | Cell Mol Immunol | 2021 | 31767975 | PubTator, text mining | PubMed |
| The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies. | Cancer Drug Resist | 2020 | 35582611 | PubTator, text mining | PubMed |
| Serum levels of microRNA-21 and microRNA-10a can predict long-term prognosis in laryngeal cancer patients: a multicenter study. | Transl Cancer Res | 2020 | 35117730 | PubTator, text mining | PubMed |
| Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAs. | Mol Biomed | 2020 | 35006436 | PubTator, text mining | PubMed |
| RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications. | Innovation (Camb) | 2020 | 34557726 | PubTator, text mining | PubMed |
| Intravenous injection of autologous bone marrow-derived mesenchymal stem cells on the gene expression and plasma level of CCL5 in refractory rheumatoid arthritis. | J Res Med Sci | 2020 | 33912221 | PubTator, text mining | PubMed |
| Anti-Tumor Mechanisms Associated With Regulation of Non-Coding RNA by Active Ingredients of Chinese Medicine: A Review. | Front Oncol | 2020 | 33680956 | PubTator, text mining | PubMed |
| The Potential of Exosomal RNAs in Atherosclerosis Diagnosis and Therapy. | Front Neurol | 2020 | 33643177 | PubTator, text mining | PubMed |
| Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis. | Front Endocrinol (Lausanne) | 2020 | 33597922 | PubTator, text mining | PubMed |
| MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy. | Front Cell Dev Biol | 2020 | 33569382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=50